Vermont Clinical Trials
Browse actively recruiting clinical trials with research sites in Vermont. Corterve gathers current studies from the public ClinicalTrials.gov registry so you can explore them by city and condition. Participation is voluntary; this page is general information and not medical advice.
Recruiting studies in Vermont
- Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and RadiationNCT07615049PHASE3SWOG Cancer Research NetworkRecurrent Soft Tissue Sarcoma of the Trunk and ExtremitiesSaint Johnsbury, VT
- Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)NCT07393555PHASE2SWOG Cancer Research NetworkRecurrent Lung Non-Small Cell CarcinomaSaint Johnsbury, VT
- Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaNCT06172296PHASE3National Cancer Institute (NCI)Ganglioneuroblastoma, NodularBurlington, VT
- Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLNCT07007312PHASE3Kura Oncology, Inc.Acute Myeloid Leukemia (AML)Burlington, VT
- A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and OlderNCT07282665PHASE3PfizerClostridoides Difficile Associated DiseaseBurlington, VT
- Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaNCT06307665PHASE3AstraZenecaAsthmaBurlington, VT
- A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)NCT06124157PHASE2National Cancer Institute (NCI)B Acute Lymphoblastic LeukemiaBurlington, VT
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic AtrophyNCT06541704PHASE3Regeneron PharmaceuticalsAge-related Macular Degeneration (AMD)Burlington, VT
- Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung CancerNCT06890598PHASE3Eli Lilly and CompanyCarcinoma, Non-Small-Cell LungBurlington, VT
- Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC TrialNCT06770582PHASE2National Cancer Institute (NCI)Non-Muscle Invasive Bladder Urothelial CarcinomaBerlin Corners, VT
- A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseaseNCT07174310PHASE3Hoffmann-La RocheParkinson's DiseaseBurlington, VT
- Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal SarcomaNCT04031677PHASE3European Organisation for Research and Treatment of Cancer - EORTCRetroperitoneal SarcomaBurlington, VT
Popular conditions in Vermont
Frequently asked questions
- How do I find clinical trials in Vermont?
- Corterve aggregates actively recruiting clinical trials with sites in Vermont from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.
- Are clinical trials in Vermont free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- What kinds of clinical trials are available in Vermont?
- Vermont research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.